Ribociclib: all 118 studies that test it

Page 2 of 2. Open to participants first (20), then studies with results posted, then the rest; newest registration first within each.

• [18F]FLT PET/CT in Rb+ Metastatic Breast CancerActive, not recruitingNCT02608216Phase 1
• A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast CancerCompletedNCT02599363Phase 1
• A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated LiposarcomaStatus unknownNCT02571829Phase 2
• Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011CompletedNCT02431481Phase 1
• Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and NeckTerminatedNCT02429089Phase 1
• Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or LymphomaTerminatedNCT02414724Phase 1
• Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011CompletedNCT02388620Phase 1
• Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With MyelofibrosisCompletedNCT02370706Phase 1
• Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic GliomaStatus unknownNCT02345824Phase 1
• Detect V / CHEVENDO (Chemo vs. Endo)Active, not recruitingNCT02344472Phase 3
• Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With LiposarcomaCompletedNCT02343172Phase 1
• A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast CancerCompletedNCT02333370Phase 1
• Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.CompletedNCT02292550Phase 1
• Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.CompletedNCT02154776Phase 1
• DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).CompletedNCT02035813Phase 2
• A Phase I Study of LEE011 in Asian PatientsCompletedNCT01898845Phase 1
• Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast CancerActive, not recruitingNCT01872260Phase 1/2
• A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma.CompletedNCT01237236Phase 1

← Ribociclib overview